263 related articles for article (PubMed ID: 19885576)
1. Medical management of brain metastases from lung cancer (Review).
Yamanaka R
Oncol Rep; 2009 Dec; 22(6):1269-76. PubMed ID: 19885576
[TBL] [Abstract][Full Text] [Related]
2. An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer.
Tsakonas G; Lewensohn R; Botling J; Ortiz-Villalon C; Micke P; Friesland S; Nord H; Lindskog M; Sandelin M; Hydbring P; Ekman S
Eur J Cancer; 2020 Jun; 132():24-34. PubMed ID: 32325417
[TBL] [Abstract][Full Text] [Related]
3. Treatment of brain metastases from lung cancer: chemotherapy.
Schuette W
Lung Cancer; 2004 Aug; 45 Suppl 2():S253-7. PubMed ID: 15552807
[TBL] [Abstract][Full Text] [Related]
4. [Multimodal Treatment of Non-Small Cell Lung Cancer with Cerebral Metastases].
Kudelin N; Bölükbas S; Schirren J
Zentralbl Chir; 2015 Jun; 140(3):328-33. PubMed ID: 26114639
[TBL] [Abstract][Full Text] [Related]
5. Novel Treatment Strategies for Brain Metastases in Non-small-cell Lung Cancer.
Bui N; Woodward B; Johnson A; Husain H
Curr Treat Options Oncol; 2016 May; 17(5):25. PubMed ID: 27085533
[TBL] [Abstract][Full Text] [Related]
6. Systemic therapies in the treatment of non-small-cell lung cancer brain metastases.
Lukas RV; Kumthekar P; Rizvi S; Salgia R
Future Oncol; 2016; 12(8):1045-58. PubMed ID: 26888310
[TBL] [Abstract][Full Text] [Related]
7. A systematic approach to the management of patients with brain metastases of known or unknown primary site.
Kyritsis AP; Markoula S; Levin VA
Cancer Chemother Pharmacol; 2012 Jan; 69(1):1-13. PubMed ID: 22042515
[TBL] [Abstract][Full Text] [Related]
8. Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG).
Christodoulou C; Kalogera-Fountzila A; Karavasilis V; Kouvatseas G; Papandreou CN; Samantas E; Varaki K; Papadopoulos G; Bobos M; Rallis G; Razis E; Goudopoulou A; Kalogeras KT; Syrigos KN; Fountzilas G
J Neurooncol; 2017 Sep; 134(2):443-451. PubMed ID: 28687923
[TBL] [Abstract][Full Text] [Related]
9. Multimodality management of non-small cell lung cancer patients with brain metastases.
Ricciardi S; de Marinis F
Curr Opin Oncol; 2010 Mar; 22(2):86-93. PubMed ID: 20009927
[TBL] [Abstract][Full Text] [Related]
10. Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.
Tian J; Luo Y; Xiang J; Tang J
J Neurooncol; 2017 Nov; 135(2):217-227. PubMed ID: 28726172
[TBL] [Abstract][Full Text] [Related]
11. Brain metastases from non-small cell lung carcinoma: Changing concepts for improving patients' outcome.
Rancoule C; Vallard A; Guy JB; Espenel S; Diao P; Chargari C; Magné N
Crit Rev Oncol Hematol; 2017 Aug; 116():32-37. PubMed ID: 28693798
[TBL] [Abstract][Full Text] [Related]
12. Medical treatment of brain metastases from lung cancer.
Cappuzzo F
Suppl Tumori; 2002; 1(4):S58-9. PubMed ID: 12415823
[No Abstract] [Full Text] [Related]
13. The impact of systemic treatment on brain metastasis in patients with non-small-cell lung cancer: A retrospective nationwide population-based cohort study.
Lee JS; Hong JH; Sun S; Won HS; Kim YH; Ahn MS; Kang SY; Lee HW; Ko YH
Sci Rep; 2019 Dec; 9(1):18689. PubMed ID: 31822734
[TBL] [Abstract][Full Text] [Related]
14. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
[TBL] [Abstract][Full Text] [Related]
15. Paradigm shift of therapeutic management of brain metastases in EGFR-mutant non-small cell lung cancer in the era of targeted therapy.
Sekine A; Satoh H
Med Oncol; 2017 Jul; 34(7):121. PubMed ID: 28555261
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer prognosis before and after recurrence in a population-based setting.
Consonni D; Pierobon M; Gail MH; Rubagotti M; Rotunno M; Goldstein A; Goldin L; Lubin J; Wacholder S; Caporaso NE; Bertazzi PA; Tucker MA; Pesatori AC; Landi MT
J Natl Cancer Inst; 2015 Jun; 107(6):djv059. PubMed ID: 25802059
[TBL] [Abstract][Full Text] [Related]
17. Brain metastases in non-small-cell lung cancer.
Dawe DE; Greenspoon JN; Ellis PM
Clin Lung Cancer; 2014 Jul; 15(4):249-57. PubMed ID: 24954227
[TBL] [Abstract][Full Text] [Related]
18. [Lung cancer: an update in 2010].
Besse B; Vignot S; Soria JC
Bull Cancer; 2010 Jan; 97(1):161-9. PubMed ID: 20028651
[TBL] [Abstract][Full Text] [Related]
19. Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.
Yao ZH; Liao WY; Ho CC; Chen KY; Shih JY; Chen JS; Lin ZZ; Lin CC; Chih-Hsin Yang J; Yu CJ
Oncologist; 2017 Sep; 22(9):1075-1083. PubMed ID: 28507206
[TBL] [Abstract][Full Text] [Related]
20. Study on lung cancer cells expressing VEGFR2 and the impact on the effect of RHES combined with radiotherapy in the treatment of brain metastases.
Jiang XD; Ding MH; Qiao Y; Liu Y; Liu L
Clin Lung Cancer; 2014 Mar; 15(2):e23-9. PubMed ID: 24374073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
